These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34697141)

  • 41. Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model.
    Yamamoto M; Zhao M; Hiroshima Y; Zhang Y; Shurell E; Eilber FC; Bouvet M; Noda M; Hoffman RM
    PLoS One; 2016; 11(8):e0160882. PubMed ID: 27500926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.
    Murakami T; Singh AS; Kiyuna T; Dry SM; Li Y; James AW; Igarashi K; Kawaguchi K; DeLong JC; Zhang Y; Hiroshima Y; Russell T; Eckardt MA; Yanagawa J; Federman N; Matsuyama R; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
    Oncotarget; 2016 Jul; 7(30):47556-47564. PubMed ID: 27286459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose-response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium.
    Gill J; Zhang W; Zhang Z; Roth M; Harrison DJ; Rowshan S; Erickson S; Gatto G; Kurmasheva R; Houghton P; Teicher B; Smith MA; Kolb EA; Gorlick R
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28606. PubMed ID: 32706456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma.
    Sampson VB; Vetter NS; Zhang W; Patil PU; Mason RW; George E; Gorlick R; Kolb EA
    Oncotarget; 2016 Dec; 7(52):86594-86607. PubMed ID: 27863409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model.
    Robl B; Botter SM; Pellegrini G; Neklyudova O; Fuchs B
    J Exp Clin Cancer Res; 2016 Jul; 35(1):113. PubMed ID: 27421768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A combination of irinotecan/cisplatinum and irinotecan/temozolomide or tumor-targeting Salmonella typhimurium A1-R arrest doxorubicin- and temozolomide-resistant myxofibrosarcoma in a PDOX mouse model.
    Kiyuna T; Tome Y; Murakami T; Miyake K; Igarashi K; Kawaguchi K; Oshiro H; Higuchi T; Miyake M; Sugisawa N; Zhang Z; Razmjooei S; Wangsiricharoen S; Chmielowski B; Nelson SD; Russell TA; Dry SM; Li Y; Eckardt MA; Singh AS; Chawla S; Kanaya F; Eilber FC; Singh SR; Zhao M; Hoffman RM
    Biochem Biophys Res Commun; 2018 Nov; 505(3):733-739. PubMed ID: 30292411
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    Hamada K; Aoki Y; Yamamoto J; Hozumi C; Zhao M; Murata T; Sugisawa N; Bouvet M; Tsunoda T; Hoffman RM
    In Vivo; 2021; 35(6):3067-3071. PubMed ID: 34697138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pioglitazone, an agonist of PPARγ, reverses doxorubicin-resistance in an osteosarcoma patient-derived orthotopic xenograft model by downregulating P-glycoprotein expression.
    Higuchi T; Sugisawa N; Miyake K; Oshiro H; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Kline Z; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
    Biomed Pharmacother; 2019 Oct; 118():109356. PubMed ID: 31545293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-fat diet promotes tumor growth in the patient-derived orthotopic xenograft (PDOX) mouse model of ER positive endometrial cancer.
    Shen K; Shen D; Jin D; Zheng Y; Zhu Y; Zhao X; Zhang Z; Wang N; Chen H; Yang L
    Sci Rep; 2023 Oct; 13(1):16537. PubMed ID: 37783734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide.
    Kawaguchi K; Igarashi K; Murakami T; Kiyuna T; Zhao M; Zhang Y; Nelson SD; Russell TA; Dry SM; Singh AS; Chmielowski B; Li Y; Unno M; Eilber FC; Hoffman RM
    Cell Cycle; 2017 Jul; 16(13):1288-1294. PubMed ID: 28622068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patient-derived orthotopic xenograft (PDOX) nude mouse model of soft-tissue sarcoma more closely mimics the patient behavior in contrast to the subcutaneous ectopic model.
    Hiroshima Y; Zhang Y; Zhang N; Uehara F; Maawy A; Murakami T; Mii S; Yamamoto M; Miwa S; Yano S; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Endo I; Hoffman RM
    Anticancer Res; 2015 Feb; 35(2):697-701. PubMed ID: 25667448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant methioninase in combination with doxorubicin (DOX) overcomes first-line DOX resistance in a patient-derived orthotopic xenograft nude-mouse model of undifferentiated spindle-cell sarcoma.
    Igarashi K; Kawaguchi K; Li S; Han Q; Tan Y; Murakami T; Kiyuna T; Miyake K; Miyake M; Singh AS; Eckardt MA; Nelson SD; Russell TA; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Singh SR; Eilber FC; Hoffman RM
    Cancer Lett; 2018 Mar; 417():168-173. PubMed ID: 29306021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Response of Triple-negative Breast Cancer Liver Metastasis to Oral Recombinant Methioninase in a Patient-derived Orthotopic Xenograft (PDOX) Model.
    Lim HI; Yamamoto J; Han Q; Sun YU; Nishino H; Tashiro Y; Sugisawa N; Tan Y; Choi HJ; Nam SJ; Bouvet M; Hoffman RM
    In Vivo; 2020; 34(6):3163-3169. PubMed ID: 33144420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The First Mouse Model of Primary Osteosarcoma of the Breast.
    Wu NF; Wu J; Yamamoto J; Aoki Y; Hozumi C; Bouvet M; Hoffman RM
    In Vivo; 2021; 35(4):1979-1983. PubMed ID: 34182472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model.
    Kiyuna T; Tome Y; Murakami T; Kawaguchi K; Igarashi K; Miyake K; Miyake M; Li Y; Nelson SD; Dry SM; Singh AS; Russell TA; Elliott I; Singh SR; Kanaya F; Eilber FC; Hoffman RM
    BMC Cancer; 2018 Aug; 18(1):840. PubMed ID: 30126369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient-derived orthotopic xenograft models of sarcoma.
    Igarashi K; Kawaguchi K; Murakami T; Miyake K; Kiyuna T; Miyake M; Hiroshima Y; Higuchi T; Oshiro H; Nelson SD; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Singh SR; Tsuchiya H; Hoffman RM
    Cancer Lett; 2020 Jan; 469():332-339. PubMed ID: 31639427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel anionic-phosphate-platinum complex effectively targets an undifferentiated pleomorphic sarcoma better than cisplatinum and doxorubicin in a patient-derived orthotopic xenograft (PDOX).
    Igarashi K; Kawaguchi K; Murakami T; Kiyuna T; Miyake K; Yamamoto N; Hayashi K; Kimura H; Nelson SD; Dry SM; Li Y; Singh AS; Miwa S; Odani A; Eilber FC; Tsuchiya H; Hoffman RM
    Oncotarget; 2017 Sep; 8(38):63353-63359. PubMed ID: 28968995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug Screening.
    Kiyuna T; Murakami T; Tome Y; Igarashi K; Kawaguchi K; Russell T; Eckardt MA; Crompton J; Singh A; Bernthal N; Bukata S; Federman N; Kanaya F; Eilber FC; Hoffman RM
    J Cell Biochem; 2017 Feb; 118(2):361-365. PubMed ID: 27357060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Patient-Derived Orthotopic Xenograft Model of Gastroesophageal-Junction Adenocarcinoma Translated to the Clinic by Tumor-Targeting Fluorescent Antibodies to Carcinoembryonic-Antigen-Related Cell-Adhesion Molecules.
    Turner MA; Amirfakhri S; Nishino H; Lwin TM; Savides TJ; Reid TR; Singer BB; Hoffman RM; Bouvet M
    In Vivo; 2021; 35(4):1959-1963. PubMed ID: 34182469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.